Regeneron Pharmaceuticals, Inc.
- SEC CIK
- 0000872589
- Latest filing
- Aug 7, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 6, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 2
- −2 vs. Q3 2025
- Portfolio value
- $33.8M
- −$666.6M (−95.2%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NTLAIntellia Therapeutics, Inc. | COM | 3,702,995 | $33.3M | 98.5% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 60,511 | $509.5K | 1.5% | −907,672−93.8% | Reduced | History |
Sold out since Q3 2025 (2)
Positions held at the end of Q3 2025 that are gone from this filing.